Compare AXON & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | TEVA |
|---|---|---|
| Founded | 1993 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 30.2B |
| IPO Year | 2001 | N/A |
| Metric | AXON | TEVA |
|---|---|---|
| Price | $535.41 | $33.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $767.85 | $37.25 |
| AVG Volume (30 Days) | 1.3M | ★ 7.8M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $2,779,536,000.00 | N/A |
| Revenue This Year | $26.35 | N/A |
| Revenue Next Year | $24.35 | $2.97 |
| P/E Ratio | $363.04 | ★ $28.19 |
| Revenue Growth | ★ 33.47 | N/A |
| 52 Week Low | $396.41 | $12.47 |
| 52 Week High | $885.92 | $37.35 |
| Indicator | AXON | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.44 | 51.50 |
| Support Level | $508.72 | $30.70 |
| Resistance Level | $586.37 | $35.32 |
| Average True Range (ATR) | 24.34 | 0.82 |
| MACD | 17.39 | -0.22 |
| Stochastic Oscillator | 85.22 | 27.41 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, productivity and real-time operations software, body cameras, in-car cameras, TASER energy devices, drones and robotic security, and training solutions. The company's operation comprises of two operating segments, Software and Sensors, and TASER. The company generates the majority of its revenue from the Software and Sensors segment, which is engaged in developing, manufacturing, and selling fully integrated hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.